Hence, in-depth profiling of cellular differences in response to changes in the abundance of SFA, MUFA, and VLCFAs, as well as the activity of ABCD1 and SCD1, is likely to provide increased insight into X-ALD disease pathology. The gene discussed is SCD; the disease is X-linked adrenoleukodystrophy.